Your browser doesn't support javascript.
loading
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial.
Oaknin, Ana; Gladieff, Laurence; Martínez-García, Jerónimo; Villacampa, Guillermo; Takekuma, Munetaka; De Giorgi, Ugo; Lindemann, Kristina; Woelber, Linn; Colombo, Nicoletta; Duska, Linda; Leary, Alexandra; Godoy-Ortiz, Ana; Nishio, Shin; Angelergues, Antoine; Rubio, Maria Jesús; Fariñas-Madrid, Lorena; Yamaguchi, Satoshi; Lorusso, Domenica; Ray-Coquard, Isabelle; Manso, Luis; Joly, Florence; Alarcón, Jesús; Follana, Philippe; Romero, Ignacio; Lebreton, Coriolan; Pérez-Fidalgo, J Alejandro; Yunokawa, Mayu; Dahlstrand, Hanna; D'Hondt, Véronique; Randall, Leslie M.
Affiliation
  • Oaknin A; Medical Oncology Service, Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain. Electronic address: aoaknin@vhio.net.
  • Gladieff L; Oncopole Claudius Regaud, IUCT, Toulouse, France.
  • Martínez-García J; Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.
  • Villacampa G; SOLTI Breast Cancer Research Group, Barcelona, Spain; Vall d'Hebron Institute of Oncology, Barcelona, Spain; The Institute of Cancer Research, London, UK.
  • Takekuma M; Shizuoka Cancer Center, Shizuoka, Japan.
  • De Giorgi U; IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori, Meldola, Italy.
  • Lindemann K; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Oslo University Hospital, Oslo, Norway.
  • Woelber L; University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Colombo N; Gynecologic Oncology Department, European Institute of Oncology IRCCS Milan, Milan, Italy; Department of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy.
  • Duska L; University of Virginia Cancer Center, Charlottesville, VA, USA.
  • Leary A; Gustave Roussy, Villejuif, France.
  • Godoy-Ortiz A; Hospital Regional de Málaga, Málaga, Spain.
  • Nishio S; Kurume University Hospital, Fukuoka, Japan.
  • Angelergues A; Groupe Hospitalier Diaconesses Croix Saint-Simon, Paris, France.
  • Rubio MJ; Hospital Universitario Reina Sofia, Córdoba, Spain.
  • Fariñas-Madrid L; Medical Oncology Service, Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Yamaguchi S; Hyogo Cancer Center, Hyogo, Japan.
  • Lorusso D; Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy; Catholic University of Sacred Heart, Rome, Italy.
  • Ray-Coquard I; Centre Léon Bérard, Lyon, France.
  • Manso L; Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Joly F; Centre François Baclesse, Caen, France.
  • Alarcón J; Hospital Universitari Son Espases, Mallorca, Spain.
  • Follana P; Centre Antoine Lacassagne, Nice, France.
  • Romero I; Fundacion Instituto Valenciano de Oncologia, Valencia, Spain.
  • Lebreton C; Institut Bergonié, Bordeaux, France.
  • Pérez-Fidalgo JA; University Hospital of Valencia, Valencia, Spain; INCLIVA Biomedical Research Institute, Valencia, Spain; CIBERONC, Valencia, Spain.
  • Yunokawa M; Cancer Institute Hospital of JFCR, Tokyo, Japan.
  • Dahlstrand H; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; Karolinska University Hospital, Stockholm, Sweden.
  • D'Hondt V; Institut du Cancer de Montpellier, Montpellier, France.
  • Randall LM; Massey Comprehensive Cancer Center, VCUHealth, Richmond, VA, USA.
Lancet ; 403(10421): 31-43, 2024 Jan 06.
Article in En | MEDLINE | ID: mdl-38048793
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Uterine Cervical Neoplasms Limits: Female / Humans Language: En Journal: Lancet Year: 2024 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Uterine Cervical Neoplasms Limits: Female / Humans Language: En Journal: Lancet Year: 2024 Document type: Article Country of publication: